HealthData.Gov
In silico discovery of novel Retinoic Acid Receptor agonist structures
Background Several Retinoic Acid Receptors (RAR) agonists have therapeutic activity against a variety of cancer types; however, unacceptable toxicity profiles have hindered the development of drugs. RAR agonists…
- HTML
Updated Oct 29, 2026